At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 35 enrolled
Drug / intervention
Novel Dressingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Wound Fluid Protease Levels During Use of Novel Wound Dressing
In Brief
A Phase 4 clinical trial evaluating Novel Dressing for Venous Stasis Ulcers. Completed, enrolled 35 participants across 8 sites.
Detailed Summary
This study is being conducted to characterize the way leg wounds respond to a new type of wound dressing, compared to wounds in patients who are not using the new dressing. The investigators will collect wound fluid for biochemical analysis, and they will measure the wound healing that occurs with and without the new dressing.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVenous Stasis Ulcers
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2012
First PostedMar 2012
Primary CompletionJan 2014
TodayJul 2026
First PostedMar 30, 2012
Enrollment StartFeb 1, 2012
Primary CompletionJan 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 14.3 years ago
Interventions
Novel Dressingdevice
Topical wound dressing